Skip to primary content
Skip to secondary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Tag Archives: fattly liver disease

Fatty Liver Feast (of Articles): NAFLD 2020

Posted on July 12, 2020 by gutsandgrowth

An entire issue of Gastroenterology delved into the topics of “NAFLD 2020.”

This special May 2020 issue provides a comprehensive update on Nonalcoholic Fatty Liver Disease.

Here are a few links to some of the articles:

  • TG Cotter, M Rinella. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
  • M Eslam, AJ Sanyal, J George. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease This article similar to a previous article (Improving Fatty Liver Nomenclature) suggests changing the name for NAFLD to MAFLD.
  • D Goldner, JE Lavine. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges

Related blog posts:

  • Pediatric NAFLD: You Don’t Have to be Obese/Overweight to have Fatty Liver Disease (but it helps)
  • Should Teenagers with Severe NAFLD Undergo Bariatric Surgery?
  • Concise Review: Fatty Liver in Pediatrics
  • Reaching Consensus on Bariatric Intervention in Children …
  • Is a Three Year-Old Too Young for Bariatric Surgery …
  • Should We Be Excited About a New Medication (Liraglutide …
  • Overlooking Obesity in Hospitalized Children | gutsandgrowth
  • Treating diabetes with surgery | gutsandgrowth

Posted in Hepatology, Pediatric Gastroenterology Liver Disease | Tagged fattly liver disease, MAFLD, nonalcoholic fatty liver disease

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Top Posts & Pages

  • Get Ready for 2021 Coding Changes
  • "Being a Doctor Will Never Be the Same After A.I."
  • Tofacitinib Outperformed Vedolizumab in Anti-TNF-experienced Ulcerative Colitis
  • ESPGHAN Position Paper: Management of Foreign Bodies (2026)
  • GI Bleeding -Forrest Classification
  • PODIUM Study: Jak Inhibitors and Ustekinumab Outperformed Vedolizumab as a 2nd Line Agent for Ulcerative Colitis
  • Dr. Joel Rosh: Positioning Therapies for Pediatric Ulcerative Colitis
  • An Esophageal Coin with Moth Eaten Appearance
  • Personal Quest Update: The Beginning of the End for the Penny & World Button Battery Day
  • Foreign Body Retrieval: You Never Know What You Will See

Log-In

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com

Recent Posts

  • PODIUM Study: Jak Inhibitors and Ustekinumab Outperformed Vedolizumab as a 2nd Line Agent for Ulcerative Colitis
  • ESPGHAN Position Paper: Management of Foreign Bodies (2026)
  • “Being a Doctor Will Never Be the Same After A.I.”
  • Measles Cases Continue to Climb
  • Outcomes of Biliary Atresia in Large Cohort
  • AI for Capsule Endoscopy:
  • Long-Term Effectiveness of Dupilumab for Eosinophilic Esophagitis
Blog at WordPress.com.
  • Subscribe Subscribed
    gutsandgrowth
    Join 1,027 other subscribers

    Have a WordPress.com account? Log in now.

  • gutsandgrowth
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar
Loading Comments...